Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management

Pulse 2.0

Twist Bioscience (TWST) Stock Dropped 19.92%: Details

Pulse 2.0

Galecto (GLTO) Stock Increases Over 4% Today: Details

Pulse 2.0

Akero Therapeutics (AKRO) Stock: Why It Fell Over 6% Today

Pulse 2.0

Akero Therapeutics (AKRO) Stock: Why It Surged Over 119% Today

Pulse 2.0

Quanterix (QTRX) Stock: Why It Increased Over 4% Today

Pulse 2.0

Mersana Therapeutics (MRSN) Stock: Why It Surged Over 29% Today

Pulse 2.0

Zai Lab (ZLAB) Stock: Why It Increased Over 7% Today

Labiotech.eu

Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence

Pulse 2.0

Beam Therapeutics (BEAM) Stock: Why It Fell Over 3% Today

MedCity News

FDA hits pause on Beam Therapeutics’ off-the-shelf cell therapy for blood cancers

Pulse 2.0

Pliant Therapeutics (PLRX) Stock: $33 Target And Outperform Rating

Pulse 2.0

Olema Pharmaceuticals (OLMA) Stock: Why It Increased Over 9% Today

Pulse 2.0

Pliant Therapeutics (PLRX) Stock: Why It Skyrocketed Over 60% Today

Pulse 2.0

Kezar Life Sciences (KZR) Stock: Why It Surged 43.43%

Pulse 2.0

Scholar Rock Holding (SRRK) Stock Price: Why It Increased 10.91% Today

Pulse 2.0

Akero Therapeutics (AKRO) Stock Price: Why It Jumped Up Over 13% Today

Pulse 2.0

Olema Pharmaceuticals (OLMA) Stock Price: Why It Increased Over 8% Today

Pulse 2.0

Twist Bioscience (TWST) Stock Price: Why It Increased 2.39%

Pulse 2.0

Olema Pharmaceuticals (OLMA) Stock: Why The Price Increased 9.22% Today

Pulse 2.0

C4 Therapeutics (CCCC) Stock: $15 Price Target From BofA